Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Endo International (Methimazole Tablets, Glycopyrrolate Tablets and Meclizine Tablets)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of generic drug evaluation. The company provides Abbreviated New Drug Application for the review and approval of the medicines Methimazole Tablets, Glycopyrrolate Tablets and Meclizine Tablets.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • First Floor, Minerva House, Simmonscourt Road Ballsbridge
  • Dublin 4
  • Ireland

Endo International (Methimazole Tablets, Glycopyrrolate Tablets and Meclizine Tablets) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Endo International (Methimazole Tablets, Glycopyrrolate Tablets and Meclizine Tablets)‘s full profile, request access.

Request full access to PitchBook

Endo International (Methimazole Tablets, Glycopyrrolate Tablets and Meclizine Tablets) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Endo International (Methimazole Tablets, Glycopyrrolate Tablets and Meclizine Tablets)‘s full profile, request access.

Request full access to PitchBook

Endo International (Methimazole Tablets, Glycopyrrolate Tablets and Meclizine Tablets) Board Members (1)

Name Representing Role Since Contact
Info
0000 00000 Self Board Member 000 0000